The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies.

Rebecca Crawford,Katharine S Gries,Satish Valluri,John Fastenau,Ross Morrison,Tzu-Min Yeh,Yunsi Olyslager,Jenna D Goldberg,Jordan M Schecter,Carolyn C Jackson,William Deraedt,Lynda Doward

Cancer reports (Hoboken, N.J.)（2022）

引用 4|浏览8

暂无评分

摘要

The symptom experience reported in this study is consistent with known RRMM symptoms and HRQOL impacts. Additionally, this study highlighted that patients' treatment expectations are changing relative to their past treatment experience. Individuals living with RRMM strongly desire therapies with a treatment-free interval and minimal impact on their HRQOL.

查看译文

关键词

immunotherapy,multiple myeloma,qualitative research,treatment choices

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要